PubMed=3934070
Lenoir G.M., Vuillaume M., Bonnardel C.
The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma.
IARC Sci. Publ. 60:309-318(1985)

PubMed=3037521; DOI=10.1073/pnas.84.13.4567; PMCID=PMC305131
Masucci M.G., Torsteinsdottir S., Colombani J., Brautbar C., Klein E., Klein G.
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Proc. Natl. Acad. Sci. U.S.A. 84:4567-4571(1987)

PubMed=2645221; DOI=10.1002/ijc.2910430219
Torsteinsdottir S., Andersson M.L., Avila-Carino J., Ehlin-Henriksson B., Masucci M.G., Klein G., Klein E.
Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line.
Int. J. Cancer 43:273-278(1989)

PubMed=8108117
Albert T., Urlbauer B., Kohlhuber F., Hammersen B., Eick D.
Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
Oncogene 9:759-763(1994)

PubMed=9473234; DOI=10.1182/blood.V91.5.1680
Klangby U., Okan I., Magnusson K.P., Wendland M., Lind P., Wiman K.G.
p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
Blood 91:1680-1687(1998)

PubMed=22720208; DOI=10.4161/onci.1.1.18400; PMCID=PMC3376971
Rosen A., Bergh A.-C., Gogolak P., Evaldsson C., Myhrinder A.L., Hellqvist E., Rasul A., Bjorkholm M., Jansson M., Mansouri L., Liu A.-Q., Teh B.T., Rosenquist R., Klein E.
Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.
OncoImmunology 1:18-27(2012)